Browsing by Author Qingsong Liu

Jump to:
All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 1 to 10 of 10

Issue DateTitleAuthor(s)
2013-04Characterization of Torin2, an ATP-competitive inhibitor of mTOR, ATM, and ATRQingsong Liu; Chunxiao Xu; Sivapriya Kirubakaran, et al
2012-09Development of ATP-Competitive mTOR Inhibitors허우영; Qingsong Liu; Seong A. Kang, et al
2011-05Discovery and optimization of potent and selective benzonaphthyridinone analogs as small molecule mTOR inhibitors with improved mouse microsome stabilityQingsong Liu; Jinhua Wang; Seong A. Kang, et al
2010-09Discovery of 1-(4-(4-Propionylpiperazin-1-yl)-3-(trifluoromethyl)phenyl)-9-(quinolin-3-yl)benzo[h][1,6]naphthyridin-2(1H)-one as a Highly Potent, Selective Mammalian Target of Rapamycin (mTOR) Inhibitor for the Treatment of CancerQingsong Liu; Jae Won Chang; Jinhua Wang, et al
2011-02Discovery of 9-(6-Aminopyridin-3-yl)-1-(3-(trifluoromethyl)-phenyl)benzo[h][1,6]naphthyridin-2(1H)-one (Torin2) as a Potent, Selective, and Orally Available Mammalian Target of Rapamycin (mTOR) Inhibitor for Treatment of CancerQingsong Liu; Jinhua Wang; Seong A. Kang, et al
2013-04Discovery of a Selective Irreversible BMX Inhibitor for Prostate CancerFeiyang Liu; Xin Zhang; Ellen Weisberg, et al
2015-05Identification of novel therapeutic targets in acute leukemias with NRAS mutations using a pharmacologic approachAtsushi Nonami; Martin Sattler; Ellen Weisberg, et al
2012-03Kinome-wide Selectivity Profiling of ATP-competitive Mammalian Target of Rapamycin (mTOR) Inhibitors and Characterization of Their Binding KineticsQingsong Liu; Sivapriya Kirubakaran; 허우영, et al
2012-04Selective ATP-Competitive Inhibitors of TOR Suppress Rapamycin-Insensitive Function of TORC2 in Saccharomyces cerevisiaeQingsong Liu; Tao Ren; Tara Fresques, et al
2012Systematic identification of genomic markers of drug sensitivity in cancer cellsMathew J. Garnett; Elena J. Edelman; Sonja J. Heidorn, et al

BROWSE